We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.08T
AUM Growth
+$79.9B
Cap. Flow
-$8.94B
Cap. Flow %
-0.83%
Top 10 Hldgs %
25.7%
Holding
3,000
New
159
Increased
1,164
Reduced
1,499
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.45B
2
PINS icon
Pinterest
PINS
+$1.89B
3
TMUS icon
T-Mobile US
TMUS
+$1.89B
4
ZM icon
Zoom
ZM
+$1.77B
5
PATH icon
UiPath
PATH
+$1.71B

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$3.66B
2
CAT icon
Caterpillar
CAT
+$1.32B
3
NFLX icon
Netflix
NFLX
+$1.18B
4
MXIM
Maxim Integrated Products
MXIM
+$1.15B
5
MU icon
Micron Technology
MU
+$1.07B

Sector Composition

Rank Sector Weight
1 Technology 24.62%
2 Healthcare 16.07%
3 Consumer Discretionary 15.29%
4 Communication Services 13.46%
5 Financials 12.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WVVI icon
2776
Willamette Valley Vineyards
WVVI
$11.7M
$148K ﹤0.01%
10,850
KLDO
2777
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$144K ﹤0.01%
19,356
-3,571
-16% -$25.3K
ENZ
2778
DELISTED
Enzo Biochem, Inc.
ENZ
$142K ﹤0.01%
44,800
-11,563
-21% -$36.4K
YARW
2779
Yarrow Bioscience, Inc. Common Stock
YARW
$113M
$141K ﹤0.01%
45
+9
+25% +$35.6K
INFI
2780
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$140K ﹤0.01%
46,944
+7,744
+20% +$24.5K
AFI
2781
DELISTED
Armstrong Flooring, Inc.
AFI
$140K ﹤0.01%
22,600
-15,000
-40% -$86.1K
AGPU
2782
Axe Compute Inc
AGPU
$95.6M
$139K ﹤0.01%
+354
New +$123K
PZN
2783
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$139K ﹤0.01%
12,618
+489
+4% +$5.4K
ARC
2784
DELISTED
ARC Document Solutions, Inc.
ARC
$137K ﹤0.01%
63,502
CMCT
2785
Creative Media & Community Trust
CMCT
$14.6M
$136K ﹤0.01%
+1
New +$268K
PBYI icon
2786
Puma Biotechnology
PBYI
$460M
$135K ﹤0.01%
14,668
+643
+5% +$6.51K
PGEN icon
2787
Precigen
PGEN
$2.38B
$135K ﹤0.01%
20,766
+3,351
+19% +$23.4K
MNOV icon
2788
MediciNova
MNOV
$64.5M
$134K ﹤0.01%
31,500
-3,087
-9% -$13.3K
SCPX
2789
DELISTED
Scorpius Holdings, Inc.
SCPX
$134K ﹤0.01%
5
-5
-50% -$136K
QXO
2790
QXO Inc
QXO
$16.1B
$133K ﹤0.01%
1,363
MTNB icon
2791
Matinas BioPharma
MTNB
$1.5M
$132K ﹤0.01%
3,396
OPTT icon
2792
Ocean Power Technologies
OPTT
$54.7M
$132K ﹤0.01%
+52,600
New +$130K
TLPH icon
2793
Talphera
TLPH
$63.3M
$132K ﹤0.01%
4,785
-301
-6% -$8.06K
DDMX
2794
DELISTED
DD3 Acquisition Corp. II Class A Common Stock
DDMX
$132K ﹤0.01%
13,305
+3,093
+30% +$30.7K
AP icon
2795
Ampco-Pittsburgh
AP
$193M
$131K ﹤0.01%
21,600
CIA icon
2796
Citizens
CIA
$200M
$131K ﹤0.01%
24,685
-19,875
-45% -$109K
NERV icon
2797
Minerva Neurosciences
NERV
$188M
$131K ﹤0.01%
7,038
-338
-5% -$7.28K
ENG
2798
DELISTED
ENGlobal Corp
ENG
$130K ﹤0.01%
+5,363
New +$135K
LU icon
2799
Lufax Holding
LU
$1.31B
$129K ﹤0.01%
2,850
ALDX icon
2800
Aldeyra Therapeutics
ALDX
$92.9M
$128K ﹤0.01%
+11,264
New +$135K

Similar funds

T. Rowe Price Associates's Q2 2021 Portfolio in Review

As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
  • T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
  • T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
  • T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
  • T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
  • T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.

Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.